Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.

Coombes RC., Howell S., Lord SR., Kenny L., Mansi J., Mitri Z., Palmieri C., Chap LI., Richards P., Gradishar W., Sardesai S., Melear J., O'Shaughnessy J., Ward P., Chalasani P., Arkenau T., Baird RD., Jeselsohn R., Ali S., Clack G., Bahl A., McIntosh S., Krebs MG.

DOI

10.1038/s41467-025-57535-w

Type

Journal article

Publication Date

2025-03-06T00:00:00+00:00

Volume

16

Permalink More information Close